The Global Albendazole API Market was valued at USD 89.2 Million in 2023 and is projected to reach USD 121.5 Million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 4.1% during the forecast period (2024–2030). This growth is fueled by increasing prevalence of parasitic infections, rising demand for antihelminthic drugs, and expanding pharmaceutical manufacturing capabilities across emerging markets.

As global healthcare systems prioritize tropical disease treatment and veterinary medicine expands, albendazole remains a critical therapeutic ingredient. This blog profiles the Top 10 Companies in the Albendazole API Industry—market leaders combining advanced synthesis technologies with strict regulatory compliance to serve pharmaceutical manufacturers worldwide.

---

🔟 1. Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.

Headquarters: Hanzhong, China
Key Offering: Albendazole API (98-99% purity)

As China’s largest albendazole producer, Shaanxi Hanjiang dominates the APAC market with vertically integrated manufacturing. The company holds WHO-GMP, EDQM, and US FDA certifications, supplying bulk API to 40+ countries.

Quality Initiatives:

• 1500-ton annual production capacity
• Multiple patent protections for synthesis processes
• R&D focus on polymorph control and impurity reduction

Download FREE Sample Report:
Global Albendazole API Market – View in Detailed Research Report

---

9️⃣ 2. Hubei Xingyinhe Chemical Co., Ltd.

Headquarters: Wuhan, China
Key Offering: Pharmaceutical-grade Albendazole

This specialized API manufacturer supplies European and South American markets with high-purity albendazole meeting EP and USP standards. Their continuous flow chemistry platform ensures batch-to-batch consistency.

Quality Initiatives:

• Dedicated anti-parasitic API production line
• Strict solvent recovery systems for environmental compliance

---

8️⃣ 3. Hubei Zhongjia Synthetic Pharmaceutical Co., Ltd.

Headquarters: Jingmen, China
Key Offering: Albendazole BP/EP/USP grades

A subsidiary of Zhongjia Group, this manufacturer operates one of China’s most automated albendazole facilities with robotic material handling and AI-driven quality control systems.

Quality Initiatives:

• 80% export-focused production
• First Chinese company to achieve albendazole USP-NF certification

---

7️⃣ 4. Changzhou Jialing Pharmaceutical Co., Ltd.

Headquarters: Changzhou, China
Key Offering: Albendazole micronized powder

Specializing in particle engineering, Jialing provides optimized albendazole API for enhanced bioavailability in suspension formulations and veterinary applications.

Quality Initiatives:

• Proprietary micronization technology
• GSK-approved secondary supplier

Download FREE Sample Report:
Global Albendazole API Market – View in Detailed Research Report

---

6️⃣ 5. Ningxia Damo Pharmaceutical Co., Ltd.

Headquarters: Yinchuan, China
Key Offering: Albendazole for tropical disease programs

Damo Pharmaceutical supplies WHO-prequalified albendazole to global health initiatives, with special formulations for mass drug administration campaigns in endemic regions.

Quality Initiatives:

• Strategic partner for African public health programs
• Cost-optimized production for developing markets

---

5️⃣ 6. Hebei Meihe Pharmaceutical Co., Ltd.

Headquarters: Shijiazhuang, China
Key Offering: High-purity albendazole crystals

Meihe combines traditional synthesis with modern purification technologies to produce albendazole with <99.5% purity for critical care formulations.

Quality Initiatives:

• Zero defect regulatory inspection history
• Investment in continuous manufacturing pilot plant

---

4️⃣ 7. Henan Houyi Pharmaceutical Company

Headquarters: Zhengzhou, China
Key Offering: Albendazole API and intermediates

With complete backward integration, Houyi controls the entire albendazole value chain from raw materials to finished API, ensuring supply security.

Quality Initiatives:

• In-house benzimidazole core synthesis
• Strategic inventory for market volatility

---

3️⃣ 8. Lianyungang Yahui Pharmaceutical Chemical Co., Ltd.

Headquarters: Lianyungang, China
Key Offering: Albendazole for veterinary use

Yahui specializes in API forms optimized for animal health applications, including premixes and water-dispersible formulations for livestock treatment.

Quality Initiatives:

• Veterinary GMP compliant production
• Custom particle size distributions

---

2️⃣ 9. TEVA (Zhejiang Wanma Synthetic Medicine)

Headquarters: Hangzhou, China
Key Offering: Albendazole for generic formulations

As TEVA’s Chinese API arm, Wanma supplies albendazole to global generic drug manufacturers with full regulatory documentation support.

Quality Initiatives:

• Validated stability programs
• ANDA filing support services

---

1️⃣ 10. Supharma Chem

Headquarters: Mumbai, India
Key Offering: Cost-effective albendazole API

India’s leading albendazole supplier competes on operational excellence, offering competitive pricing without compromising quality standards.

Quality Initiatives:

• Strategic focus on African and Southeast Asian markets
• Green chemistry initiatives reducing solvent use

Get Full Report Here:
Global Albendazole API Market – View in Detailed Research Report

---

🌍 Outlook: Albendazole API Market Trends and Future Directions

The albendazole API sector is experiencing transformation, driven by stricter pharmacopoeial standards, emerging alternative benzimidazoles, and innovative drug combination therapies.

📈 Key Market Dynamics:

• China’s dominance in production (85% market share) facing regulatory scrutiny
• Increasing WHO prequalification requirements for tropical disease programs
• Growing veterinary applications driving formulation innovations
• Supply chain diversification initiatives by Western pharma companies

Get Full Report Here:
Global Albendazole API Market – View in Detailed Research Report

These market leaders are not just manufacturing APIs—they’re enabling life-saving treatments for millions battling parasitic diseases worldwide.